NRXP
NRX Pharmaceuticals, Inc.Company with tickers: NRXP, NRXPW
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2020-09-30 | $299,253 Δ | 10-Q, filed 2020-11-16 |
| 2020-06-30 | $0 Δ | 10-Q, filed 2020-08-14 |
| 2020-03-31 | $25,997,965 | 10-Q, filed 2020-05-15 |
| 2019-09-30 | $8,891,378 Δ | 10-Q, filed 2020-11-16 |
| 2019-06-30 | $22,099,233 Δ | 10-Q, filed 2020-08-14 |
| 2019-03-31 | $0 | 10-Q, filed 2020-05-15 |
| 2018-09-30 | $0 Δ | 10-Q, filed 2019-11-14 |